Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2023/01/049304
CTRI/2023/01/049304
Not yet recruiting
Phase 2

Clinical efficacy of topical ophthalmic application of Guduchi Ghrita versus sodium chromoglycate 2% eye drops in Vernal Keratoconjunctivitis

Department of Shalakya Tantra0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Department of Shalakya Tantra
Status
Not yet recruiting
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Department of Shalakya Tantra

Eligibility Criteria

Inclusion Criteria

  • •1\.Males or females 4 to 18 years of age.
  • •2\.Active VKC
  • •3\.Patients were required to have experienced 1 or more recurrences of VKC during the previous year.
  • •4\.Only the patients (or patientâ??s guardian) who consent to be included in the study and sign on the consent form attached as annexure 1 will be included in the study.

Exclusion Criteria

  • •1\.Patients will be excluded if they demonstrated ocular anomalies other than VKC affecting the ocular surface.
  • •2\.Abnormalities of lid anatomic features, nasolacrimal drainage, or blinking function.
  • •3\.Active ocular infection or history of ocular herpes, varicella zoster or vaccinia virus infection.
  • •4\.Any ocular disease that would require topical ocular treatment during the study.
  • •5\.Presence or history of severe systemic allergy at study entry.
  • •6\.Topical or systemic corticosteroids within 1 week; topical or systemic immunosuppressive drug within 90 days before enrolment.
  • •7\.Scraping of the vernal plaque within 1 month; or any other ocular surgery within 6 months before baseline.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Clinical study about ophthalmic local administrations of Triamcinolone acetonide for macular edema and/or retinal periphlebitis
JPRN-UMIN000005778Department of Ophthalmology and Visual Sciences, Yamagata University School of Medicine100
Completed
Phase 2
Comparison of effect of topical ophthalmic drop tacrolimus 1% versus topical ophthalmic drop dexamethasone 1% in the treatment of patients with shield ulcer
IRCT2016110630746N1Vice chancellor for research, Zahedan University of Medical Sciences20
Completed
Not Applicable
Administration of Topical Ophthalmic Medication (ATOM): Feasibility of the spraynozzle technique.n.v.t. onderzoek wordt verricht op gezonde vrijwilligersn.v.t.
NL-OMON37543Medspray XMEMS BV20
Recruiting
Not Applicable
Efficacy of timolol in arresting progression in KeratoconusHealth Condition 1: null- Keratoconus
CTRI/2017/09/009859I120
Recruiting
Not Applicable
Evaluation of efficacy of topical application of ring worm extract in the treatment of diabetic foot
IRCT20180523039810N1Mashhad University of Medical Sciences20